Drug-Makers Paying Off Competitors To Keep Cheap Generics Off MarketQuicklink submitted by Darren Wolfe Permalink
Become a Fan
|Over the last few years, drug-makers have embraced a startlingly simple tactic for fending off competition from generic brands: paying them off.|
The time limit for entering new comments on this Quicklink has expired.
This limit can be removed. Our paid membership program is designed to give you many benefits, such as removing this time limit. To learn more, please click here.